ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > Activin RIIB

Activin RIIB

概要

Name:Activin receptor type-2B
Target Synonym:EC:2.7.11.30,EC 2.7.11,Activin receptor type IIB,ACVR2B,Activin A Receptor Type 2B,Activin A Receptor, Type IIB,Activin Receptor Type-2B,EC 2.7.11.30,ActR-IIB,ACTRIIB,HTX4
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase 2 Clinical

ライセンス

Project Name Modality Therapeutic Area Indications Stage Right Available
ActRIIB inhibitor Small molecule Oncology/Cancer Cancer cachexia Preclinical Global

製品リスト製品比較と製品注文

製品仕様別:
製品カテゴリー別:
種類別:
コンジュゲート:
製造番号 種類 製品説明 構造 純度 特徴
ACB-H82E3 Human Biotinylated Human Activin RIIB Protein, His,Avitag™
ACB-H82E3-structure
ACB-H82E3-sds
ACB-H5226 Human Human Activin RIIB / ACVR2B Protein, His Tag
ACB-H5226-structure
ACB-H5226-sds
ACRO Quality

生物活性データの一部

ACB-H82E3-SPR
 Activin RIIB SPR

Biotinylated Human Activin RIIB Protein, His,Avitag (Cat. No. ACB-H82E3) immobilized on CM5 Chip can bind Human Latent Activin A, His Tag (Cat. No. ACA-H424x) with an affinity constant of 0.147 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

ACB-H5226-SPR
 Activin RIIB SPR

Human Activin RIIB, His Tag (Cat. No. ACB-H5226) immobilized on CM5 Chip can bind Human Activin A, premium grade (Cat. No. ACA-H421b) with an affinity constant of 0.216 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

Synonym Name

ACVR2B,ACTRIIB,MGC116908

Background

Activin receptor type-2B (ACVR2B) is also known as ActR-IIB and MGC116908, ACVR2B is an activin type 2 receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. This gene encodes activin A type IIB receptor, which displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor. Defects in ACVR2B are the cause of visceral heterotaxy autosomal type 4 (HTX4).

Clinical and Translational Updates

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
Bimagrumab BYM-338; LY-3985863 Phase 2 Clinical Morphosys Ag, Novartis Pharma Ag Diabetes Mellitus, Type 2; Myositis, Inclusion Body; Obesity; Pulmonary Disease, Chronic Obstructive; Sarcopenia Details
BIIB-110 BIIB-110; BIIB110; ALG-801 Phase 1 Clinical Alivegen USA Inc Muscular Diseases; Muscular Atrophy, Spinal Details
LAE-123 LAE-123 Details

This web search service is supported by Google Inc.

totopphone